ADMA Biologics, Inc. (ADMA)
9.255
+0.06
(+0.71%)
USD |
NASDAQ |
Apr 06, 13:56
ADMA Biologics SG&A Expense (TTM) : 96.42M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Inovio Pharmaceuticals, Inc. | 32.68M |
| ANI Pharmaceuticals, Inc. | 317.74M |
| AtriCure, Inc. | 311.02M |
| Ligand Pharmaceuticals, Inc. | 92.45M |